BOSTON--(BUSINESS WIRE)--Mar. 3, 2015--
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
today announced that the company will present at the 27th Annual
ROTH Conference on Monday, March 9 at 3:30 p.m. PT at the Ritz-Carlton
in Dana Point, CA.
A live webcast of the presentation will be available on the company's
website at www.verastem.com.
An archived presentation will be available for 90 days.
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to
treat cancer by the targeted killing of cancer stem cells. Cancer stem
cells are an underlying cause of tumor recurrence and
metastasis. Verastem is developing small molecule inhibitors of
signaling pathways that are critical to cancer stem cell survival and
proliferation including FAK and PI3K/mTOR. For more information, please
visit www.verastem.com.
Source: Verastem, Inc.
Verastem, Inc.
Brian Sullivan, 781-292-4214
bsullivan@verastem.com
